CVS Health Corp.

  • Market Cap: Large Cap
  • Industry: Retailing
  • ISIN: US1266501006
USD
71.48
-3.33 (-4.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,05,678.00
1,02,882.00
98,942.00
94,609.00
97,504.00
95,409.00
91,324.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,05,678.00
1,02,882.00
98,942.00
94,609.00
97,504.00
95,409.00
91,324.00
Raw Material Cost
92,126.00
89,065.00
85,322.00
80,192.00
84,811.00
82,870.00
77,851.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
33,066.00
32,020.00
31,317.00
29,135.00
29,543.00
29,922.00
27,853.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
769.00
767.00
768.00
779.00
754.00
746.00
727.00
Selling and Distribution Expenses
11,235.00
10,858.00
10,306.00
10,343.00
10,481.00
10,516.00
10,236.00
Other Expenses
-3,383.50
-3,278.70
-3,208.50
-2,991.40
-3,029.70
-3,066.80
-2,858.00
Total Expenditure (Excl Depreciation)
1,03,361.00
99,923.00
95,628.00
90,535.00
95,292.00
93,386.00
88,087.00
Operating Profit (PBDIT) excl Other Income
2317
2959
3314
4074
2212
2023
3237
Other Income
26.00
481.00
7.00
1.00
227.00
38.00
-71.00
Operating Profit (PBDIT)
3,490.00
4,574.00
4,492.00
5,229.00
3,586.00
3,222.00
4,317.00
Interest
769.00
767.00
768.00
779.00
754.00
746.00
727.00
Exceptional Items
-220.00
-6,155.00
-906.00
-679.00
441.00
-1,210.00
-102.00
Gross Profit (PBDT)
13,552.00
13,817.00
13,620.00
14,417.00
12,693.00
12,539.00
13,473.00
Depreciation
1,147.00
1,134.00
1,171.00
1,154.00
1,147.00
1,161.00
1,151.00
Profit Before Tax
1,354.00
-3,482.00
1,647.00
2,617.00
2,126.00
105.00
2,337.00
Tax
-1,569.00
508.00
634.00
835.00
503.00
34.00
569.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,943.00
-3,975.00
1,021.00
1,779.00
1,644.00
87.00
1,770.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,943.00
-3,975.00
1,021.00
1,779.00
1,644.00
87.00
1,770.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-20.00
-15.00
-8.00
3.00
-21.00
-16.00
-2.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,923.00
-3,990.00
1,013.00
1,782.00
1,623.00
71.00
1,768.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
75,214.00
72,928.00
77,379.00
76,929.00
75,560.00
74,944.00
74,930.00
Earnings per share (EPS)
2.3
-3.13
0.8
1.41
1.3
0.07
1.41
Diluted Earnings per share
2.3
-3.13
0.8
1.41
1.3
0.07
1.41
Operating Profit Margin (Excl OI)
2.19%
2.88%
3.35%
4.31%
2.27%
2.12%
3.54%
Gross Profit Margin
2.37%
-2.28%
2.85%
3.99%
3.36%
1.33%
3.82%
PAT Margin
2.78%
-3.86%
1.03%
1.88%
1.69%
0.09%
1.94%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 8.38% vs 3.77% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 80.10% vs -20.71% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 3.13% vs -30.77% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 1.99% vs 10.23% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of CVS Health Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,05,678.00
5,646.08
1,00,031.92
1,771.71%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,05,678.00
5,646.08
1,00,031.92
1,771.71%
Raw Material Cost
92,126.00
4,550.48
87,575.52
1,924.53%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
33,066.00
0.00
33,066.00
Power Cost
0
0
0.00
Manufacturing Expenses
769.00
72.66
696.34
958.35%
Selling and Distribution Expenses
11,235.00
1,167.72
10,067.28
862.13%
Other Expenses
-3,383.50
-7.27
-3,376.23
-46,440.58%
Total Expenditure (Excl Depreciation)
1,03,361.00
5,718.20
97,642.80
1,707.58%
Operating Profit (PBDIT) excl Other Income
2,317.00
-72.12
2,389.12
3,312.70%
Other Income
26.00
24.09
1.91
7.93%
Operating Profit (PBDIT)
3,490.00
21.00
3,469.00
16,519.05%
Interest
769.00
72.66
696.34
958.35%
Exceptional Items
-220.00
-886.76
666.76
75.19%
Gross Profit (PBDT)
13,552.00
1,095.60
12,456.40
1,136.95%
Depreciation
1,147.00
69.03
1,077.97
1,561.60%
Profit Before Tax
1,354.00
-1,007.46
2,361.46
234.40%
Tax
-1,569.00
2.34
-1,571.34
-67,151.28%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
2,943.00
-1,009.79
3,952.79
391.45%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,943.00
-1,009.79
3,952.79
391.45%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
-20.00
0.00
-20.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,923.00
-1,009.79
3,932.79
389.47%
Equity Capital
0
0
0.00
Face Value
0.01
1.00
0.00
Reserves
75,214.00
-1,908.18
77,122.18
4,041.66%
Earnings per share (EPS)
2.30
-18.26
20.56
112.60%
Diluted Earnings per share
2.30
-18.26
20.56
112.60%
Operating Profit Margin (Excl OI)
2.19%
-1.28%
0.00
3.47%
Gross Profit Margin
2.37%
-16.62%
0.00
18.99%
PAT Margin
2.78%
-17.88%
0.00
20.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 10,567.80 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 2.72% vs 3.98% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 8.38% vs 3.77% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 292.30 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 173.26% vs -493.88% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 80.10% vs -20.71% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 346.40 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -15.37% vs -8.74% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 3.13% vs -30.77% in Dec 2024

Quarterly - Interest
Interest 76.90 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.26% vs -0.13% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 1.99% vs 10.23% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.19%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024